Targeting Breast Cancer Tumor Antigens for Immunotherapy - 2018-2019 Renewal - Renewal - 1

Medicine & Life Sciences

1. Neoplasm Antigens 100%
2. Immunotherapy 82%
3. Breast Neoplasms 59%
4. Mass Spectrometry 37%
5. T-Lymphocytes 25%
6. Ligands 22%
7. Epitopes 20%
8. Peptides 19%
9. Neoplasms 19%
10. Cancer Vaccines 16%
11. Histocompatibility Antigens Class I 16%
12. T-Cell Antigen Receptor 14%
13. Proteomics 12%
14. Cell Line 12%
15. Antigens 8%
16. Informatics 8%
17. T-Lymphocyte Epitopes 8%
18. Mutation 7%
19. Workflow 7%
20. Antigen Presentation 7%
21. Proteome 7%
22. Cell- and Tissue-Based Therapy 6%
23. bis(p-chlorophenyl)acetic acid 6%
24. Staphylococcal protein A-sepharose 5%